- Report
- June 2018
- 15 Pages
Global
- Report
- May 2018
- 15 Pages
Global
- Report
- February 2018
- 15 Pages
Global
- Report
- January 2018
- 15 Pages
Global
- Report
- March 2018
- 15 Pages
Global
- Report
- April 2024
- 175 Pages
From €4821EUR$5,000USD£4,123GBP
- Report
- April 2024
- 175 Pages
From €4821EUR$5,000USD£4,123GBP
- Report
- October 2023
- 90 Pages
Japan
From €3374EUR$3,500USD£2,886GBP
- Report
- February 2022
- 198 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- September 2021
- 246 Pages
Global
From €3071EUR$3,185USD£2,626GBP
€4387EUR$4,550USD£3,752GBP
- Report
- August 2022
- 112 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- January 2022
- 114 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- January 2022
- 115 Pages
Global
From €4579EUR$4,750USD£3,917GBP
- Report
- April 2020
- 63 Pages
Global
- Report
- June 2018
- 70 Pages
Global
From €4772EUR$4,950USD£4,081GBP
- Report
- February 2023
- 100 Pages
Global
From €2651EUR$2,750USD£2,267GBP
- Report
- August 2022
- 119 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- November 2021
- 106 Pages
Global
From €4338EUR$4,500USD£3,710GBP
- Report
- July 2022
- 280 Pages
Global
From €3471EUR$3,600USD£2,968GBP
- Report
- July 2022
- 96 Pages
Middle East, Africa
From €1446EUR$1,500USD£1,237GBP
High Throughput Screening (HTS) is a technology used in the diagnostics market to rapidly identify compounds that interact with a target of interest. HTS is used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics. It is a powerful tool for drug discovery and development, as it can quickly identify compounds that interact with a target of interest. HTS can also be used to identify potential biomarkers for diagnostics, as it can quickly identify molecules that interact with a target of interest.
HTS is used in a variety of diagnostic applications, including cancer diagnostics, infectious disease diagnostics, and genetic diagnostics. HTS can be used to identify potential drug candidates, biomarkers, and other molecules that can be used in diagnostics.
Some companies in the HTS market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, and Thermo Fisher Scientific. Show Less Read more